WO2000006705A3 - Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie - Google Patents
Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie Download PDFInfo
- Publication number
- WO2000006705A3 WO2000006705A3 PCT/DE1999/002309 DE9902309W WO0006705A3 WO 2000006705 A3 WO2000006705 A3 WO 2000006705A3 DE 9902309 W DE9902309 W DE 9902309W WO 0006705 A3 WO0006705 A3 WO 0006705A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stem cells
- genetically modified
- negative
- gene therapy
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000562487A JP4012688B2 (ja) | 1998-07-24 | 1999-07-22 | 遺伝子修飾したcd34−陰性付着成長性幹細胞および遺伝子療法におけるそれらの使用 |
US09/743,904 US6361997B1 (en) | 1998-07-24 | 1999-07-22 | Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy |
AU61872/99A AU741168B2 (en) | 1998-07-24 | 1999-07-22 | Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy |
CA002338541A CA2338541C (en) | 1998-07-24 | 1999-07-22 | Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
EP99948706A EP1100878B8 (de) | 1998-07-24 | 1999-07-22 | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen |
AT99948706T ATE296875T1 (de) | 1998-07-24 | 1999-07-22 | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen |
DE59912118T DE59912118D1 (de) | 1998-07-24 | 1999-07-22 | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833476.1 | 1998-07-24 | ||
DE19833476A DE19833476B4 (de) | 1998-07-24 | 1998-07-24 | Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000006705A2 WO2000006705A2 (de) | 2000-02-10 |
WO2000006705A3 true WO2000006705A3 (de) | 2000-05-04 |
Family
ID=7875274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1999/002309 WO2000006705A2 (de) | 1998-07-24 | 1999-07-22 | Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie |
Country Status (9)
Country | Link |
---|---|
US (1) | US6361997B1 (de) |
EP (1) | EP1100878B8 (de) |
JP (1) | JP4012688B2 (de) |
AT (1) | ATE296875T1 (de) |
AU (1) | AU741168B2 (de) |
CA (1) | CA2338541C (de) |
DE (2) | DE19833476B4 (de) |
ES (1) | ES2242422T3 (de) |
WO (1) | WO2000006705A2 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001005944A1 (en) * | 1999-07-20 | 2001-01-25 | University Of Southern California | Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US20020045260A1 (en) * | 2000-10-17 | 2002-04-18 | Shih-Chieh Hung | Method of isolating mesenchymal stem cells |
US7560280B2 (en) | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
CA2438501C (en) * | 2001-02-14 | 2014-09-16 | Leo T. Furcht | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
US20070111201A1 (en) * | 2001-04-30 | 2007-05-17 | Benjamin Doranz | Reverse transfection of cell arrays for structural and functional analyses of proteins |
DE10144326B4 (de) * | 2001-09-10 | 2005-09-22 | Siemens Ag | Verfahren und System zur Überwachung eines Reifenluftdrucks |
ITRM20030376A1 (it) | 2003-07-31 | 2005-02-01 | Univ Roma | Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia. |
US11660317B2 (en) | 2004-11-08 | 2023-05-30 | The Johns Hopkins University | Compositions comprising cardiosphere-derived cells for use in cell therapy |
US20100093089A1 (en) * | 2006-11-09 | 2010-04-15 | Eduardo Marban | Dedifferentiation of adult mammalian cardiomyocytes into cardiac stem cells |
US9005964B2 (en) * | 2006-11-24 | 2015-04-14 | Regents Of The University Of Minnesota | Endodermal progenitor cells |
ES2401608T3 (es) * | 2007-05-24 | 2013-04-23 | Apceth Gmbh & Co. Kg | Blastocitos CD34 mesenquimales para uso en terapia génica de diabetes |
US9845457B2 (en) | 2010-04-30 | 2017-12-19 | Cedars-Sinai Medical Center | Maintenance of genomic stability in cultured stem cells |
US9249392B2 (en) | 2010-04-30 | 2016-02-02 | Cedars-Sinai Medical Center | Methods and compositions for maintaining genomic stability in cultured stem cells |
EP2625577B1 (de) | 2010-10-08 | 2019-06-26 | Terumo BCT, Inc. | Anpassbares verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem |
US9884076B2 (en) | 2012-06-05 | 2018-02-06 | Capricor, Inc. | Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy |
EP2882445B1 (de) | 2012-08-13 | 2019-04-24 | Cedars-Sinai Medical Center | Exosomen und mikroribonukleinsäuren zur geweberegeneration |
US9617506B2 (en) | 2013-11-16 | 2017-04-11 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
CN106232800B (zh) | 2014-03-25 | 2020-07-03 | 泰尔茂比司特公司 | 介质的被动替代 |
JP6830059B2 (ja) | 2014-09-26 | 2021-02-17 | テルモ ビーシーティー、インコーポレーテッド | スケジュール化された細胞フィーディング |
JP6878274B2 (ja) | 2014-10-03 | 2021-05-26 | シーダーズ−サイナイ・メディカル・センターCedars−Sinai Medical Center | 筋ジストロフィーの処置における心筋球由来細胞およびこのような細胞によって分泌されたエキソソーム |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3402543B1 (de) | 2016-01-11 | 2021-09-08 | Cedars-Sinai Medical Center | Aus kardiosphäre stammende zellen und durch solche zellen sekretierte exosomen in der behandlung von herzversagen mit konservierter auswurffraktion |
EP3464565A4 (de) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | Zellexpansion |
WO2017210652A1 (en) | 2016-06-03 | 2017-12-07 | Cedars-Sinai Medical Center | Cdc-derived exosomes for treatment of ventricular tachyarrythmias |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
EP3515459A4 (de) | 2016-09-20 | 2020-08-05 | Cedars-Sinai Medical Center | Kardiosphärenzellen und deren extrazelluläre vesikel zur verzögerung oder umkehr des alterungsprozesses und altersbedingten erkrankungen |
EP3656841A1 (de) | 2017-03-31 | 2020-05-27 | Terumo BCT, Inc. | Zellexpansion |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
JP2020516654A (ja) | 2017-04-13 | 2020-06-11 | センティ バイオサイエンシズ インコーポレイテッド | 組み合わせがん免疫療法 |
EP3612191A4 (de) | 2017-04-19 | 2020-12-30 | Cedars-Sinai Medical Center | Verfahren und zusammensetzungen zur behandlung von skelettmuskeldystrophie |
WO2019126068A1 (en) | 2017-12-20 | 2019-06-27 | Cedars-Sinai Medical Center | Engineered extracellular vesicles for enhanced tissue delivery |
JP2022512766A (ja) | 2018-10-17 | 2022-02-07 | センティ バイオサイエンシズ インコーポレイテッド | 組み合わせがん免疫療法 |
US11419898B2 (en) | 2018-10-17 | 2022-08-23 | Senti Biosciences, Inc. | Combinatorial cancer immunotherapy |
WO2022204315A1 (en) | 2021-03-23 | 2022-09-29 | Terumo Bct, Inc. | Cell capture and expansion |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995002038A1 (en) * | 1993-07-09 | 1995-01-19 | Ohio University Edison Animal Biotechnology Institute | Yolk sac stem cells and their uses |
US5691176A (en) * | 1990-10-30 | 1997-11-25 | Applied Immune Sciences, Inc. | Recombinant adeno-associated virus vector packaging cells and methods for use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5921856A (en) | 1997-07-10 | 1999-07-13 | Sp3, Inc. | CVD diamond coated substrate for polishing pad conditioning head and method for making same |
-
1998
- 1998-07-24 DE DE19833476A patent/DE19833476B4/de not_active Expired - Fee Related
-
1999
- 1999-07-22 US US09/743,904 patent/US6361997B1/en not_active Expired - Lifetime
- 1999-07-22 ES ES99948706T patent/ES2242422T3/es not_active Expired - Lifetime
- 1999-07-22 EP EP99948706A patent/EP1100878B8/de not_active Expired - Lifetime
- 1999-07-22 JP JP2000562487A patent/JP4012688B2/ja not_active Expired - Fee Related
- 1999-07-22 CA CA002338541A patent/CA2338541C/en not_active Expired - Fee Related
- 1999-07-22 WO PCT/DE1999/002309 patent/WO2000006705A2/de active IP Right Grant
- 1999-07-22 AU AU61872/99A patent/AU741168B2/en not_active Ceased
- 1999-07-22 DE DE59912118T patent/DE59912118D1/de not_active Expired - Lifetime
- 1999-07-22 AT AT99948706T patent/ATE296875T1/de active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691176A (en) * | 1990-10-30 | 1997-11-25 | Applied Immune Sciences, Inc. | Recombinant adeno-associated virus vector packaging cells and methods for use |
WO1995002038A1 (en) * | 1993-07-09 | 1995-01-19 | Ohio University Edison Animal Biotechnology Institute | Yolk sac stem cells and their uses |
Non-Patent Citations (4)
Title |
---|
HUSS ET AL: "CD34-NEGATIVE HEMATOPOIETIC STEM CELLS ISOLATED FROM HUMAN PERIPHERAL BLOOD CELLS AS ULTIMATE PRECURSORS OF HEMATOPOIETIC PROGENITORS", INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, vol. 24, 1997, pages 404 - 409, XP002130242 * |
HUSS: "APPLICATIONS OF HEMATOPOIETIC STEM CELLS AND GENE TRANSFER", INFUSIONSTHERAPIE UN TRANSFUSIONSMEDIZIN, vol. 23, 1996, pages 147 - 160, XP000876760 * |
ROLLING F ET AL: "AAV AS A VIRAL VECTOR FOR HUMAN GENE THERAPY", MOLECULAR BIOTECHNOLOGY,US,TOTOWA, NJ, vol. 3, no. 1, 1 February 1995 (1995-02-01), pages 9 - 15, XP002014055, ISSN: 1073-6085 * |
VERHASSELT ET AL: "RETROVIRALLY TRANSDUCED CD34++ HUMAN CORD BLOOD CELLS GENERATE T CELLS EXPRESSING HIGH LEVELS OF THE RETROVIRAL ENCODED GREEN FLUORESCENT PROTEIN MARKER IN VITRO", BLOOD, vol. 91, 15 July 1998 (1998-07-15), pages 431 - 440, XP002130243 * |
Also Published As
Publication number | Publication date |
---|---|
CA2338541C (en) | 2007-04-03 |
AU741168B2 (en) | 2001-11-22 |
EP1100878B1 (de) | 2005-06-01 |
ATE296875T1 (de) | 2005-06-15 |
AU6187299A (en) | 2000-02-21 |
ES2242422T3 (es) | 2005-11-01 |
DE19833476B4 (de) | 2005-08-25 |
CA2338541A1 (en) | 2000-02-10 |
US6361997B1 (en) | 2002-03-26 |
DE59912118D1 (de) | 2005-07-07 |
EP1100878A2 (de) | 2001-05-23 |
DE19833476A1 (de) | 2000-01-27 |
JP2003527817A (ja) | 2003-09-24 |
JP4012688B2 (ja) | 2007-11-21 |
EP1100878B8 (de) | 2005-08-17 |
WO2000006705A2 (de) | 2000-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000006705A3 (de) | Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie | |
Terai et al. | Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway | |
Suchánek et al. | Human dental pulp stem cells-isolation and long term cultivation | |
CN102282252B (zh) | 羊膜来源的贴壁细胞 | |
Zhu et al. | Periodontal ligament stem cells: current status, concerns, and future prospects | |
Tew et al. | Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells | |
PT1084230E (pt) | Regulação da diferenciação de células estaminais hematopoiéticas através da utilização de células estaminais mesenquimatosas humanas | |
JP2002538181A5 (de) | ||
SE0201328D0 (sv) | Hematopoietic differentiation of human embryonic stem cells | |
WO2000073421A3 (en) | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells | |
IL210618A (en) | Cell cultures containing isolated and multiplied human cells other than embryonic and germ cells, pharmaceutical preparations containing them, methods of preparation, and methods for identifying modulators and differentiation factors. | |
Dai et al. | Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells | |
JPH1189587A (ja) | 遺伝的に改変された細胞および疾患の予防または治療におけるそれらの使用 | |
Pantic et al. | Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts | |
Olmedo-Moreno et al. | Heterogeneity of in vitro expanded mesenchymal stromal cells and strategies to improve their therapeutic actions | |
Cao et al. | Regenerative potential of pluripotent nontumorgenetic stem cells: Multilineage differentiating stress enduring cells (Muse cells) | |
KR20170036105A (ko) | 치료학적 용도의 줄기 세포 조성물 및 줄기 세포의 제조 방법 | |
Tabuchi et al. | Establishment and characterization of a colonic epithelial cell line MCE301 from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene | |
ATE400654T1 (de) | Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört | |
Murakami et al. | Isolation and characterization of lymphoid enhancer factor-1-positive deciduous dental pulp stem-like cells after transfection with a piggyBac vector containing LEF1 promoter-driven selection markers | |
Krylova et al. | Cellular spheroids obtained from mesenchymal stem cells derived from bone marrow and limb muscle of early human embryo | |
DE50009932D1 (de) | Gentransfer in humane lymphocyten mittels retroviraler scfv-zelltargeting vektoren | |
WO2019183042A1 (en) | Autologous mitochondrial extraction and expansion | |
Wu et al. | In vitro discovery of novel prokaryotic ion channel candidates for antiarrhythmic gene therapy | |
Radfar et al. | Transplantation of virally transduced cells into the dermis of immunocompetent and immunodeficient (SCID) mice to determine gene expression profile and differential donor cell survival |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 61872/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 562487 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref document number: 2338541 Country of ref document: CA Ref country code: CA Ref document number: 2338541 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999948706 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09743904 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999948706 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 61872/99 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999948706 Country of ref document: EP |